Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Blankenstein

Showing results (151-160 of 157) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 157 results.
Diabetes/Metabolism Research and Reviews|July 14, 2004
LDL oxidative modifications in well- or moderately controlled type 2 diabetesP G Scheffer, R M A Henry, E J M Wever, et al.
Journal of Neuro-Oncology|July 13, 2016
Prognostic value of the S100B protein in newly diagnosed and recurrent glioma patients: a serial analysisF K Holla, T J Postma, M A Blankenstein, et al.
Neurology|December 16, 2011
Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohortN S M Schoonenboom, F E Reesink, N A Verwey, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 25, 2012
CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndromeM Khalil, C Enzinger, C Langkammer, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 19, 2002
Aromatase and COX-2 expression in human breast cancersA M Brodie, Q Lu, B J Long, et al.
Annals of Clinical Biochemistry|April 4, 2009
A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's diseaseN A Verwey, W M van der Flier, K Blennow, et al.
Neurology|February 4, 2012
Age and diagnostic performance of Alzheimer disease CSF biomarkersN Mattsson, E Rosén, O Hansson, et al.
Pageof 16

Showing results (151-160 of 157) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 157 results.
Diabetes/Metabolism Research and Reviews|July 14, 2004
LDL oxidative modifications in well- or moderately controlled type 2 diabetesP G Scheffer, R M A Henry, E J M Wever, et al.
Journal of Neuro-Oncology|July 13, 2016
Prognostic value of the S100B protein in newly diagnosed and recurrent glioma patients: a serial analysisF K Holla, T J Postma, M A Blankenstein, et al.
Neurology|December 16, 2011
Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohortN S M Schoonenboom, F E Reesink, N A Verwey, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 25, 2012
CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndromeM Khalil, C Enzinger, C Langkammer, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 19, 2002
Aromatase and COX-2 expression in human breast cancersA M Brodie, Q Lu, B J Long, et al.
Annals of Clinical Biochemistry|April 4, 2009
A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's diseaseN A Verwey, W M van der Flier, K Blennow, et al.
Neurology|February 4, 2012
Age and diagnostic performance of Alzheimer disease CSF biomarkersN Mattsson, E Rosén, O Hansson, et al.
Pageof 16